Mylan's Generic Cabazitaxel Receives Approval in the U.S.
After years of back-and-forth with several generics makers, Sanofi came out on top in its latest Jevtana litigation, successfully blocking generic competition to the prostate cancer drug from Novartis’ Sandoz.
Accord's Generic Cabazitaxel Receives Approval in the U.S.
Natco Pharma on Monday said its partner Breckenridge Pharmaceutical Inc has received approval from the US health regulator for generic Cabazitaxel intravenous powder used in the treatment of prostate cancer.
Accord healthcare`s Generic Cabazitaxel Receives Approval in the US
Apotex's Generic Cabazitaxel Receives Approval in the U.S.
Dr. Reddy`s Generic Cabazitaxel Receives Approval in the U.S.
Starpharma has reported positive interim data from the prostate cancer arm of the Phase II trial of its clinical-stage asset, DEP cabazitaxel.
CHICAGO (Reuters) - Pfizer PFE.N and BioNTech's BNTX.O COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, the companies said on Wednesday, paving the way for them to seek U.S. and European approval to use the shot in this age group within weeks.
AstraZeneca has completed a clearout (PDF) of its midphase pipeline, dumping a clutch of cancer, diabetes and cardiovascular disease drugs it picked up in deals including its $1 billion takeover of Ardea Biosciences.